Essential cookies by default. The browser ID, load-time metrics and error replays only run if you choose "Accept all".
Head-to-head evidence comparison — which supplement is right for you?
Clindamycin (topical) vs Tazarotene: Tazarotene has the stronger overall evidence (7.5 vs 6.5/10); they're alternatives for clearer skin (acne) — the best pick depends on your goals. Take the 2-minute quiz for a pick tailored to your goals.
Tazarotene wins 2 of 3 categories. Both are solid choices — the best pick depends on your specific goals.
Verdict
Too few graded studies
Top outcomes
Verdict
Too few graded studies
Top outcomes
Shared outcomes (1)
Outcomes where both Clindamycin (topical) and Tazarotene have evidence — compare verdict strength side-by-side.
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Morning
Fixed-dose clindamycin 1% with benzoyl peroxide
A source-matched dose range is not available for this product and use.
If this treatment was prescribed for you, follow your prescriber’s directions. Do not change prescribed treatment because this page has no matched dose range.
Evening
Tazarotene 0.045% lotion
long-term
long-term
long-term
long-term
immediate
12 weeks
24 weeks
1-4 weeks
Topical antibiotic monotherapy only provides mild benefit for patients with acne vulgaris: a systematic review and network meta-analysis
Clin Drug Investig (2026) · Meta-Analysis · n=22645
32 studies comprising 34 randomised controlled trials, 22,645 patients, searched to October 2025.
Efficacy of topical treatments for mild-to-moderate acne: a systematic review and meta-analysis of randomized controlled trials
J Eur Acad Dermatol Venereol (2025) · Meta-Analysis · n=33472
35 randomised clinical trials, 33,472 participants, nine topical agents, minimum 12 weeks of treatment.
Meta-analysis comparing efficacy of benzoyl peroxide, clindamycin, benzoyl peroxide with salicylic acid, and combination benzoyl peroxide/clindamycin in acne
J Am Acad Dermatol (2010) · Meta-Analysis · n=7309
23 studies, 7,309 patients, conducted under Cochrane guidance and reported to PRISMA.
Tazarotene 0.045% Lotion for Once-Daily Treatment of Moderate-to-Severe Acne Vulgaris: Results from Two Phase 3 Trials
J Drugs Dermatol (2020) · RCT · n=1614
The two identical phase 3 registration trials for the 0.045% lotion — 1614 subjects aged 9 and older.
New Polymeric Once-Daily Tazarotene 0.045% Lotion Formulation for Moderate-to-Severe Acne: Pooled Phase 3 Pediatric Analysis
J Drugs Dermatol (2020) · RCT · n=684
A pooled paediatric SUBGROUP analysis of the two phase 3 trials, not a separate trial: 136 patients aged 10-13 and 548 aged 14-17.
Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial
Arch Dermatol (2002) · RCT · n=563
The long photodamage trial: 24 weeks double-blind, then a 28-week open-label extension — 12 months in total, 563 patients.
Tazarotene has a higher evidence score (7.5/10 vs 6.5/10) and wins in 2 of 3 categories.
For clearer skin (acne), Tazarotene has a higher relevance score (88 vs 62).
No documented interaction was found in the data searched. This does not establish that this exact combination is safe.
The right pick depends on your goals. Answer a few quick questions for a personalised recommendation — or dig into the full evidence on each.